Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CS 2100 (1-[[4-Ethyl-5-[5-(4-phenoxyphenyl)-1,2,4-oxadiazol-3-yl]-2-thienyl]methyl]-3-azetidinecarboxylic acid) is an S1P1 agonist.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 41.00 | |
5 mg | In stock | $ 97.00 | |
10 mg | In stock | $ 155.00 | |
25 mg | In stock | $ 312.00 | |
50 mg | In stock | $ 493.00 | |
100 mg | In stock | $ 725.00 |
Description | CS 2100 (1-[[4-Ethyl-5-[5-(4-phenoxyphenyl)-1,2,4-oxadiazol-3-yl]-2-thienyl]methyl]-3-azetidinecarboxylic acid) is an S1P1 agonist. |
Targets&IC50 | S1P1 (human):4.0 nM (EC50) |
Synonyms | 1-[[4-Ethyl-5-[5-(4-phenoxyphenyl)-1,2,4-oxadiazol-3-yl]-2-thienyl]methyl]-3-azetidinecarboxylic acid |
Molecular Weight | 461.53 |
Formula | C25H23N3O4S |
CAS No. | 913827-99-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: < 2 mg/mL (insoluble or slightly soluble)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CS 2100 913827-99-3 GPCR/G Protein S1P Receptor inhibit 1-[[4-Ethyl-5-[5-(4-phenoxyphenyl)-1,2,4-oxadiazol-3-yl]-2-thienyl]methyl]-3-azetidinecarboxylic acid LPL Receptor Inhibitor immunosuppressive efficacy HvGR CS2100 CS-2100 Lysophospholipid Receptor S1P3-sparing inhibitor